Date

Tuesday, 03 June 2014

Location

European Medicines Agency, Amsterdam, the Netherlands

This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. Participants will be updated on a number of EMA initiatives including RMP summaries, conflicts of interest policy and access to clinical trial data policy. The European Commission will provide updates on the new clinical trial regulation and a study on off-label use. Feedback from four NCAs involving patients and healthcare professionals in regulatory decisions will be discussed in the afternoon session. Registration by invitation only.

Documents

Share this page